Profile

Harrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, TN. The change of name to Harrow Health in January 2019 reflected a goal of "creating, investing in, operating and growing a diversified portfolio of health care businesses that meet the needs of health care providers and patients across America", according to CEO Mark Baum.